Insulet (PODD) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Insulet Corporation (PODD) PT Raised to $335 at Oppenheimer
February 24, 2023 8:55 AM ESTOppenheimer analyst Steven Lichtman raised the price target on Insulet Corporation (NASDAQ: PODD) to $335.00 (from $280.00) while maintaining a Outperform rating.
The analyst commented, "PODD's 4Q22 sales of $369.7M (+22.6% cc) far exceeded our/Street's ~$333M/$327M estimates. US Omnipod at $276.2M beat our... More
